Oracle (NYSE:ORCL) Price Target Raised to $202.00

Oracle (NYSE:ORCL) had its target price increased by equities researchers at Sanford C. Bernstein from $201.00 to $202.00 in a report issued on Monday, Benzinga reports. The firm currently has an “outperform” rating on the enterprise software provider’s stock. Sanford C. Bernstein’s price target points to a potential upside of 20.87% from the company’s previous close.

A number of other brokerages have also recently issued reports on ORCL. Mizuho lifted their price target on shares of Oracle from $170.00 to $185.00 and gave the company an “outperform” rating in a research report on Tuesday, September 10th. Evercore ISI raised their price objective on shares of Oracle from $160.00 to $175.00 and gave the company an “outperform” rating in a research note on Tuesday, September 10th. StockNews.com upgraded shares of Oracle from a “hold” rating to a “buy” rating in a research note on Tuesday, September 10th. Guggenheim raised their price objective on shares of Oracle from $185.00 to $200.00 and gave the company a “buy” rating in a research note on Friday, September 13th. Finally, Jefferies Financial Group raised their price objective on shares of Oracle from $170.00 to $190.00 and gave the company a “buy” rating in a research note on Monday, September 16th. Ten research analysts have rated the stock with a hold rating and twenty have assigned a buy rating to the company’s stock. Based on data from MarketBeat, Oracle presently has an average rating of “Moderate Buy” and a consensus price target of $167.42.

Oracle Trading Down 1.9 %

NYSE:ORCL opened at $167.12 on Monday. The company has a 50-day moving average price of $146.05 and a 200-day moving average price of $134.40. Oracle has a 12 month low of $99.26 and a 12 month high of $173.99. The company has a current ratio of 0.72, a quick ratio of 0.72 and a debt-to-equity ratio of 6.68. The stock has a market cap of $463.08 billion, a price-to-earnings ratio of 45.05, a P/E/G ratio of 3.05 and a beta of 1.01.

Oracle (NYSE:ORCL) last issued its quarterly earnings results on Monday, September 9th. The enterprise software provider reported $1.39 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.33 by $0.06. Oracle had a net margin of 20.40% and a return on equity of 171.38%. The company had revenue of $13.31 billion during the quarter, compared to analysts’ expectations of $13.23 billion. During the same period last year, the company posted $0.95 EPS. Oracle’s revenue was up 6.9% on a year-over-year basis. Equities analysts predict that Oracle will post 5.01 EPS for the current year.

Insider Buying and Selling at Oracle

In other Oracle news, insider Edward Screven sold 426,861 shares of Oracle stock in a transaction that occurred on Wednesday, July 10th. The shares were sold at an average price of $141.91, for a total transaction of $60,575,844.51. Following the transaction, the insider now owns 2,626,764 shares of the company’s stock, valued at $372,764,079.24. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. In other Oracle news, Chairman Lawrence Joseph Ellison sold 1,125,000 shares of Oracle stock in a transaction that occurred on Monday, July 15th. The shares were sold at an average price of $143.69, for a total transaction of $161,651,250.00. Following the transaction, the chairman now owns 1,145,732,353 shares of the company’s stock, valued at $164,630,281,802.57. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Edward Screven sold 426,861 shares of the business’s stock in a transaction on Wednesday, July 10th. The stock was sold at an average price of $141.91, for a total transaction of $60,575,844.51. Following the completion of the transaction, the insider now directly owns 2,626,764 shares in the company, valued at approximately $372,764,079.24. The disclosure for this sale can be found here. Insiders have sold 1,573,181 shares of company stock valued at $225,338,245 over the last 90 days. 42.80% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On Oracle

A number of hedge funds have recently bought and sold shares of the business. Werlinich Asset Management LLC raised its stake in Oracle by 3.1% during the second quarter. Werlinich Asset Management LLC now owns 2,325 shares of the enterprise software provider’s stock valued at $326,000 after purchasing an additional 70 shares in the last quarter. RFP Financial Group LLC raised its stake in Oracle by 2.7% during the second quarter. RFP Financial Group LLC now owns 2,869 shares of the enterprise software provider’s stock valued at $405,000 after purchasing an additional 75 shares in the last quarter. Invst LLC raised its stake in Oracle by 2.4% during the second quarter. Invst LLC now owns 3,372 shares of the enterprise software provider’s stock valued at $482,000 after purchasing an additional 79 shares in the last quarter. ERn Financial LLC raised its stake in Oracle by 0.6% during the second quarter. ERn Financial LLC now owns 12,911 shares of the enterprise software provider’s stock valued at $1,823,000 after purchasing an additional 80 shares in the last quarter. Finally, Key Financial Inc raised its stake in Oracle by 1.2% during the second quarter. Key Financial Inc now owns 6,600 shares of the enterprise software provider’s stock valued at $932,000 after purchasing an additional 80 shares in the last quarter. Hedge funds and other institutional investors own 42.44% of the company’s stock.

Oracle Company Profile

Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.